Ernexa Therapeutics Inc. business relationships
Companies named in Ernexa Therapeutics Inc.’s 10-K filed 2026-03-13, and public companies whose annual reports name Ernexa Therapeutics Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 8 / 100 Top 2% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Ernexa Therapeutics Inc.’s annual report 2
“September 2024, the Company assigned this customer contract to Factor Bioscience Limited ("Factor Limited") whereby all the” SEC filing
“License and Collaboration Agreement, effective as of September 9, 2024, with Factor Bioscience Limited |” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.